Viridian Therapeutics Inc (NAS:VRDN)
$ 12.34 0.74 (6.38%) Market Cap: 787.57 Mil Enterprise Value: 347.92 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 46/100

Q4 2021 Viridian Therapeutics Inc Earnings Call Transcript

Mar 10, 2022 / 09:30PM GMT
Release Date Price: $19.04 (-3.05%)
Operator

Greetings, and welcome to the Viridian Therapeutics Fourth Quarter and Full Year 2021 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the call over to John Jordan, Vice President of Investor Relations and Corporate Communication. Thank you. You may begin.

John Jordan;Viridian Therapeutics;Vice President
Inc.;Corporate Communications and Investor Relations,

Thank you, Daryl. Good morning, everyone, and welcome to our fourth quarter and full year conference call. Today, after the market close, we issued a press release providing our fourth quarter and full year financial results and business updates. A replay of today's call will be available on the Investor Relations section of our website 1 hour after the completion. After our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot